RSP Systems

RSP Systems develops non-invasive glucose monitoring technology using Raman spectroscopy to measure blood glucose without needles or invasive procedures. The company's GlucoBeam Smart device uses confocal near-infrared Raman spectroscopy to detect glucose signals from the upper living layers of the skin, with algorithms trained on real-world data from over 850 people and 300,000 data points across 20 clinical studies. RSP Systems holds an extensive IP portfolio spanning 8 patent families with 43 patents granted and 37 pending. Founded in 2006 and headquartered in Odense, Denmark, the company has raised approximately $32.4M in Series B funding. RSP Systems differentiates itself through its supervised machine learning approach that identifies stable spectral signals across conditions, with published research in Nature Scientific Reports demonstrating home-use performance comparable to existing CGM systems with stable calibration.